Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 125
Single User License Price INR 8899
Corporate User License Price USD 375
Corporate User License Price INR 26696
Site License Price USD 250
Site License Price INR 17798
Request a Quote

Report Title

Acadia Pharmaceuticals Inc (ACAD)-Financial and Strategic SWOT Analysis Review

Quote Request for License Type
License Type Price  
Single User License USD 125
Site License USD 250
Enterprise Wide License USD 375
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Acadia Pharmaceuticals Inc (ACAD)-Financial and Strategic SWOT Analysis Review


Quote Request for License Type
License Type Price  
Single User License USD 125
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Acadia Pharmaceuticals Inc (ACAD)-Financial and Strategic SWOT Analysis Review

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Acadia Pharmaceuticals Inc (ACAD)-Financial and Strategic SWOT Analysis Review



Executive Summary

Acadia Pharmaceuticals Inc (ACAD)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Acadia Pharmaceuticals Inc (Acadia) discovers, develops and commercializes small molecule drugs for the treatment of central nervous system disorders. Acadia's lead product Nuplazid (pimavanserin) is a FDA approved drug for the treatment of Parkinson's disease psychosis. Its other pipeline products include pimavanserin for the treatment of Alzheimer's disease agitation, Alzheimer's disease psychosis, schizophrenia inadequate response, schizophrenia negative symptoms and major depressive disorder. The company has partnerships with Allergen for the development of its drug candidates in the therapeutic areas of pain and ophthalmology. It has its operational presence with offices located in Denmark and Switzerland. Acadia is headquartered in San Diego, California, the US.

Acadia Pharmaceuticals Inc Key Recent Developments

Mar 30,2017: ACADIA Pharmaceuticals Announces Appointment of Michael J. Yang as Executive Vice President, Chief Commercial Officer

Feb 28,2017: ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016

Nov 07,2016: ACADIA Pharmaceuticals Reports Third Quarter 2016 Financial Results

Aug 24,2016: ACADIA Pharmaceuticals Announces Appointment of Todd S. Young as Executive Vice President, Chief Financial Officer

Aug 04,2016: ACADIA Pharmaceuticals Reports Second Quarter 2016 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Acadia Pharmaceuticals Inc-Key Facts 6

Acadia Pharmaceuticals Inc-Key Employees 7

Acadia Pharmaceuticals Inc-Key Employee Biographies 8

Acadia Pharmaceuticals Inc-Major Products and Services 9

Acadia Pharmaceuticals Inc-Pharmaceutical Pipeline Products Data 10

Acadia Pharmaceuticals Inc, Pipeline Products by Therapy Area 10

Acadia Pharmaceuticals Inc, Pipeline Products by Development Phase 11

Acadia Pharmaceuticals Inc-History 12

Acadia Pharmaceuticals Inc-Company Statement 14

Acadia Pharmaceuticals Inc-Locations And Subsidiaries 17

Head Office 17

Other Locations & Subsidiaries 17

Section 2-Company Analysis 18

Acadia Pharmaceuticals Inc-Business Description 18

Acadia Pharmaceuticals Inc-Corporate Strategy 19

Acadia Pharmaceuticals Inc-SWOT Analysis 20

SWOT Analysis-Overview 20

Acadia Pharmaceuticals Inc-Strengths 20

Acadia Pharmaceuticals Inc-Weaknesses 21

Acadia Pharmaceuticals Inc-Opportunities 22

Acadia Pharmaceuticals Inc-Threats 23

Acadia Pharmaceuticals Inc-Key Competitors 24

Section 3-Company Financial Ratios 25

Financial Ratios-Capital Market Ratios 25

Financial Ratios-Annual Ratios 26

Performance Chart 28

Financial Performance 28

Financial Ratios-Interim Ratios 29

Financial Ratios-Ratio Charts 30

Section 4-Company's Lifesciences Financial Deals and Alliances 31

Acadia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 31

Acadia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 32

Acadia Pharmaceuticals Inc, Recent Deals Summary 33

Section 5-Company's Recent Developments 34

Mar 30, 2017: ACADIA Pharmaceuticals Announces Appointment of Michael J. Yang as Executive Vice President, Chief Commercial Officer 34

Feb 28, 2017: ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016 35

Nov 07, 2016: ACADIA Pharmaceuticals Reports Third Quarter 2016 Financial Results 37

Aug 24, 2016: ACADIA Pharmaceuticals Announces Appointment of Todd S. Young as Executive Vice President, Chief Financial Officer 39

Aug 04, 2016: ACADIA Pharmaceuticals Reports Second Quarter 2016 Financial Results 40

May 05, 2016: ACADIA Pharmaceuticals Reports First Quarter 2016 Financial Results 42

Feb 29, 2016: ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2015 43

Jan 25, 2016: ACADIA Pharmaceuticals Appoints James R. Owen, M.D., as Senior Vice President, Clinical Development and Chief Medical Officer 44

Jan 11, 2016: ACADIA Pharmaceuticals Appoints Jim Daly to Board of Directors 45

Section 6-Appendix 46

Methodology 46

Ratio Definitions 46

About GlobalData 50

Contact Us 50

Disclaimer 50

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Acadia Pharmaceuticals Inc, Pipeline Products by Therapy Area 10

Acadia Pharmaceuticals Inc, Pipeline Products by Development Phase 11

Acadia Pharmaceuticals Inc, Performance Chart (2012-2016) 28

Acadia Pharmaceuticals Inc, Ratio Charts 30

Acadia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 31

Acadia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 32

List of Tables

Acadia Pharmaceuticals Inc, Key Facts 6

Acadia Pharmaceuticals Inc, Key Employees 7

Acadia Pharmaceuticals Inc, Key Employee Biographies 8

Acadia Pharmaceuticals Inc, Major Products and Services 9

Acadia Pharmaceuticals Inc, Number of Pipeline Products by Therapy Area 10

Acadia Pharmaceuticals Inc, Number of Pipeline Products by Development Stage 11

Acadia Pharmaceuticals Inc, History 12

Acadia Pharmaceuticals Inc, Subsidiaries 17

Acadia Pharmaceuticals Inc, Key Competitors 24

Acadia Pharmaceuticals Inc, Ratios based on current share price 25

Acadia Pharmaceuticals Inc, Annual Ratios 26

Acadia Pharmaceuticals Inc, Annual Ratios (Cont...1) 27

Acadia Pharmaceuticals Inc, Interim Ratios 29

Acadia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 31

Acadia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 32

Acadia Pharmaceuticals Inc, Recent Deals Summary 33

Currency Codes 46

Capital Market Ratios 46

Equity Ratios 47

Profitability Ratios 47

Cost Ratios 48

Liquidity Ratios 48

Leverage Ratios 49

Efficiency Ratios 49

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Sunovion Pharmaceuticals Inc Pfizer Inc Otsuka Pharmaceutical Co Ltd Forest Laboratories LLC Eisai Inc


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person